Whole-genome sequencing studies in biliary tract cancer have revealed genomic alterations in several oncogenes and tumor suppressor genes, mainly in KRAS, TP53, CDKN2A, and SMAD4 [13,14,15]. The gene discussed is KRAS; the disease is biliary tract neoplasm.